Mental Health and Metabolic Health: The Science and Art of Integrated Care
- Continuing Education
- Live Online
This course is taught online in real time.
Session Recordings will not be available for this course.
$715.50 Save with early registration
For a full list of profession pricing see below.
View All
Fee increases to $795 after
Earn up to:
26.00 AMA PRA Category 1 Credit(s) ™
26.00 ANCC contact hours
View All
3 Days + Optional 1 Day Workshop
Please view the Schedule for a full description of the program.
On This Page
Overview
Mental health and metabolic health are deeply interconnected. Mental health conditions rarely occur in isolation; they frequently co-occur with one another and with common medical illnesses such as cardiovascular disease, diabetes, obesity, cancer, and neurological disorders. These conditions often overlap, interact, or present with shared symptoms, making coordinated, integrated care essential to improving long-term outcomes—particularly for individuals with chronic illness.
People living with mental illness die, on average, 10–20 years earlier than the general population, with much of this excess mortality driven not by suicide, but by preventable cardiometabolic disease and lifestyle-related factors. At the same time, metabolic conditions such as obesity, insulin resistance, and type 2 diabetes—now increasingly prevalent—are strongly associated with higher rates of depression, anxiety, bipolar disorder, psychosis, and cognitive decline. Together, these observations underscore a growing consensus: mental and physical health are fundamentally interconnected.
A robust and expanding body of research now demonstrates shared pathophysiological pathways underlying both mental and metabolic disorders. These include chronic inflammation, immune and neuroendocrine dysregulation, insulin resistance, circadian disruption, alterations in the gut microbiome, and mitochondrial and bioenergetic dysfunction. Collectively, these mechanisms challenge traditional diagnostic silos and point toward the need for more integrated, systems-based models of care.
In many respects, this work builds on familiar foundations—such as the integration of behavioral health into primary care, attention to social determinants of health, lifestyle medicine, preventive care, and mind–body approaches. However, this conference goes further. It synthesizes emerging mechanistic science—particularly in metabolic biology—with clinical evidence, patient experience, evolving therapeutics, and real-world health system considerations. In doing so, it offers a more complete framework for understanding why mental illness so often co-occurs with metabolic disease, why standard treatments may fall short or, at times, worsen outcomes, and how targeted metabolic interventions may improve care.
Through expert lectures, interdisciplinary panels, patient perspectives, and an optional one-day clinical workshop, participants will explore how integrated metabolic and mental health approaches can complement existing treatments, inform personalized care, and support recovery. The conference emphasizes scientific rigor, clinical safety, ethical responsibility, and team-based implementation, making it relevant for physicians, psychotherapists, nurses, dietitians, health coaches, researchers, and health care leaders.
Learning Objectives
- Describe the bidirectional relationships between mental health and metabolic health.
- Explain emerging evidence linking metabolic and bioenergetic dysfunction to neuropsychiatric disorders.
- Evaluate and implement metabolic and lifestyle-based interventions—including nutrition and dietary strategies, exercise, sleep optimization, medications, supplements, stress-reduction, and light therapy—for their potential roles in mental health care.
- Apply principles of integrated, team-based care to address mental health, metabolic health, and social determinants of health simultaneously across diverse clinical settings.
Developed and Offered By:
Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by McLean Hospital.
Schedule
All agenda sessions are in Eastern Time.
Learners will be able to register for an optional workshop titled “Ketogenic Therapies for Neuropsychiatric Disorders” on Saturday, September 19, 2026. The workshop fee is $250.
Wednesday, September 16, 2026
Welcome and Introduction
8:45-9:00 am
Mental Health and Metabolic Health: Connecting the Mind, Brain, and Body
9:00-9:45 am
Mitochondria: The Science of Cellular Health
9:45-10:30 am
Break
10:30-10:45 am
The Science of Bioenergetics in Neuropsychiatric Disorders
10:45-11:30 am
Q&A Panel
11:30 am-12:00 pm
Lunch Break
12:00-1:00 pm
Aging, Mental Health, and Strategies for Resilience
1:00-1:45 pm
Immune and Inflammatory Drivers of Neuropsychiatric Disorders
1:45-2:30 pm
Break
2:30-2:45 pm
Hormones and Health
2:45-3:30 pm
Psychiatric Medications Beyond Neurotransmitters: Metabolic, Mitochondrial, and Systemic Effects
3:30-4:15 pm
Q&A Panel
4:15-5:00 pm
Thursday, September 17, 2026
Welcome and Introduction
8:45-9:00 am
Metabolism, Metabolic Health, and Mental Disorders
9:00-9:45 am
Metabolic Medications in the Treatment of Mental Disorders
9:45-10:30 am
Break
10:30-10:45 am
Obesity Medicine and Its Role in Mental Health Care
10:45-11:30 am
Panel
11:30 am-12:00 pm
Lunch Break
12:00-1:00 pm
Nutrition and Mental Health
1:00-1:45 pm
Ultra Processed Food Addiction
1:45-2:30 pm
Break
2:30-2:45 pm
Eating Disorders
2:45-3:30 pm
The Ketogenic Diet in the Treatment of Neuropsychiatric Disorders
3:30-4:15 pm
Panel
4:15-5:00 pm
Friday, September 18, 2026
Welcome and Introduction
8:45-9:00 am
Engaging Patients in Lifestyle Change
9:00-9:45 am
Exercise for the Brain
9:45-10:30 am
Break
10:30-10:45 am
Substance Use: Helping Patients Who Want to Cut Down but Not Abstain
10:45-11:30 am
Panel
11:30 am-12:00 pm
Lunch Break
12:00-1:00 pm
Sleep and Circadian Biology
1:00-1:45 pm
Relationships: A Social Determinant of Health
1:45-2:30 pm
Break
2:30-2:45 pm
Light / Photobiomodulation in the Treatment of Neuropsychiatric Disorders
2:45-3:30 pm
Building Integrated Care Teams: Training, Workflow, and Payment Models
3:30-4:15 pm
Patient Panel: Finding Recovery Through Metabolic Interventions
4:15-5:00 pm
Saturday, September 19, 2026
Optional Workshop - Ketogenic Therapies in the Treatment of Neuropsychiatric Disorders
8:45 am-5:00 pm
Welcome and Introduction
8:45-9:00 am
Ketogenic Therapies in the Treatment of Neuropsychiatric Disorders
9:00-9:45 am
How Does the Ketogenic Diet Work?
9:45-10:30 am
Break
10:30-10:45 am
Patient Selection, Indications, Contraindications, and Safety Monitoring
10:45-11:15 am
Implementing Ketogenic Therapies: Foods and Ratios
11:15 am-12:15 pm
Lunch Break (on your own)
12:15-1:15 pm
Compliance, Keto-Adaptation, and Other Challenges of Ketogenic Therapies
1:15-2:00 pm
Is the KD Bad for the Heart? A Cardiologist's Approach to Treatment
2:00-2:30 pm
Eating Disorders: Can a Ketogenic Diet Not Only Be Safe, but an Effective Treatment?
2:30-3:00 pm
Break
3:00-3:15 pm
Psychopharmacologic Management with Ketogenic Therapies
3:15-3:45 pm
Patient Journeys
3:45-4:30 pm
Q&A Panel
4:30-5:00 pm
Faculty
Harvard Medical School Continuing Education attracts the best and brightest faculty from all around the world. As a student in this course, you’ll have access to outstanding course directors and faculty.
Course Directors
Christopher Palmer
MD | Course Director
- Founder and Director, Metabolic and Mental Health Program, McLean Hospital
- Director, Department of Postgraduate and Continuing Education, McLean Hospital
- Assistant Professor of Psychiatry, Harvard Medical School
Dost Öngür
MD, PhD | Course Director
- Chief, Division of Psychotic Disorders, McLean Hospital
- Director, Schizophrenia and Bipolar Disorder Research Program, McLean Hospital
- Director, LEAP Center, McLean Hospital
Diane Bemis, BFA
Senior Administrative Assistant, McLean Hospital
Matt Bernstein, MD
Chief Medical Officer, Ellenhorn
Founding Partner, Accord
Paolo Cassano, MD, PhD
Psychiatrist, Mass General Brigham
Director, Brain Photobiomodulation Clinic Mass General Brigham
Greg Curtis, MD
Internal Medicine Physician, Signature Healthcare
Elissa Epel, PhD
Professor & Vice Chair, Department of Psychiatry & Behavioral Sciences, University of California - San Francisco
Director, Aging, Metabolism, & Emotions Center
Scott Fears, MD, PhD
Psychiatrist
Chief Medical Officer, aeme Health
Guido Frank, MD
Professor of Psychiatry, University of California - San Diego
Elizabeth Frates, MD
Immediate Past President, American College of Lifestyle Medicine
Associate Professor, Harvard Medical School
Mark Frye, MD
Consultant, Department of Psychiatry & Psychology, Mayo Clinic
Ashley Gearhardt, PhD
Professor of Psychiatry, University of Michigan
Felice Jacka, OAM
Professor of Nutritional Psychiatry, Deakin University
Founder & Director, Food & Mood Centre
Hadine Joffe, MD
Chair, Department of Psychiatry, Beth Israel Deaconess Medical Center
Professor of Psychiatry, Harvard Medical School
Roger McIntyre, MD, FRCPC
Executive Director, Brain and Cognition Discovery Foundation
Professor, Psychiatry and Pharmacology, University of Toronto
Head of Mood Disorders Psychopharmacology Unit, University Health Network
Marjorie Overhiser, BA
Conference Coordinator, McLean Hospital
Mark Pasternack, MD
MGB Infectious Disease and Global Health Clinical Faculty, Mass General Research Institute
Associate Professor of Pediatrics, Harvard Medical School
Edward Phillips, MD
Assistant Professor of Physical Medicine and Rehabilitation, Harvard Medical School
Chief, Physical Medicine & Rehabilitation Service, Boston VA Healthcare System
Martin Picard, PhD
Science of Health Associate Professor of Behavioral Medicine, Columbia University
Denise Potter, RDN, CDCES
Dietitian Consultant, Advanced Ketogenic Therapies
Jong Rho, MD
Section Chief, Child Neurology Yale-New Haven Children's Hospital
Professor of Pediatrics (Neurology)
Bret Scher, MD
Medical Director, Baszucki Group
Director, Metabolic Mind
Maya Schumer, PhD
Postdoctoral Research Fellow, Schizophrenia and Bipolar Research Program, McLean Hospital
Denise Soccio, DNP, RN
Nursing Professional Development Specialist, McLean Hospital
Robert Waldinger, MD
Director, Psychodynamic Therapy and Research, Massachusetts General Hospital
Director, Harvard Study of Adult Development
Roger Weiss, MD
Chief, Division of Alcohol, Drugs, and Addition, McLean Hospital
Director, Alcohol, Drug, and Addiction Clinical Research Program, McLean Hospital
John Winkelman, MD, PhD
Chief, Sleep Disorders Clinical Research Program, Massachusetts General Hospital
Beth Zupec-Kania ,RDN, CD
Owner, Advanced Ketogenic Therapies
Request Information
Interested in learning more about this program? Sign up for details.
Course Fees
Registration Details
You may register through our secure online environment and will receive an email confirmation upon receipt of your payment. Prices include CME credit, electronic syllabus, refreshments, continental breakfast. Session recordings will not be available for this course. At the end of the registration process, a $10 non-refundable processing fee will be added to your registration.
| Role | Course Fee | Early Registration Course Fee |
|---|---|---|
| Physician (MD/DO) | $795 | $715.50 |
| Resident/Fellow | $575 | $517.50 |
| Allied Health Professional / Other | $575 | $517.50 |
Learners will be able to register for an optional workshop titled “Ketogenic Therapies for Neuropsychiatric Disorders” on Saturday, September 19, 2026. The workshop fee is $250.
Please contact us at 617-855-3140 for the status of social work CE accreditation.